Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
about
Atypical hemolytic uremic syndromeClinical features of anti-factor H autoantibody-associated hemolytic uremic syndromeHemolytic uremic syndrome: new developments in pathogenesis and treatmentRelative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotypeAssociation of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndromeGenetic studies of IgA nephropathy: what have we learned from genome-wide association studiesCurrent Understanding of the Role of Complement in IgA NephropathyAtypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literatureCurrent treatment of atypical hemolytic uremic syndromeComplement System Part II: Role in ImmunityAn imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)Production of biologically active complement factor H in therapeutically useful quantitiesGenetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degenerationTranslational mini-review series on complement factor H: genetics and disease associations of human complement factor H.Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.Thrombomodulin mutations in atypical hemolytic-uremic syndrome.Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.Thrombotic microangiopathies: multimers, metalloprotease, and beyond.Genetics and complement in atypical HUS.aHUS caused by complement dysregulation: new therapies on the horizon.A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations.Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations.Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristicsAtypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 geneNovel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.Thrombotic microangiopathy and associated renal disorders.Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndromeComplement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathyLong-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses.A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndromeComprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.Successful treatment of DEAP-HUS with eculizumab.Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Cardiovascular complications in atypical haemolytic uraemic syndrome.A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.
P2860
Q21202864-580A3B8A-4230-40EE-9A89-718D83256338Q24606843-373D6347-52F2-49F2-90A0-15F5A4AFA44AQ24613517-9B82CF52-17B2-4F73-9366-CEF569D2E339Q24613907-2A0751AF-D031-4EEF-B5C2-8F266882B543Q24634697-45A83446-234E-495F-932A-B6B18C1B0CA5Q26829467-5098577F-4D77-4945-832E-A786522E6061Q26852163-2ACC060F-6EC5-453C-8EAF-5D79DCB18173Q26864297-EBE6949B-4340-440D-A67F-1449826AF132Q27003211-88BF489C-92B7-4FB2-B362-0F65EFEE8FD2Q28263460-59A6A79E-7624-45AD-8BBD-FFF718DE985FQ28293350-16232DF2-7BA0-4675-9324-FC3259080BC9Q28300280-5DFBF782-4029-485F-A332-0699B9D6B1A7Q33356232-2A0C9129-9ED0-4D24-A1DF-7669333536D5Q33377799-83310BED-E632-43FB-8EFD-A59F2780A500Q33385154-831C7757-F5E9-44D4-BC2B-EAD5FDD3D20BQ33385474-E06735D3-C076-4424-902F-E321C94B8E43Q33387252-35CB8579-EE87-407A-AD7F-D714359C842CQ33389435-703A0517-A922-4764-A4AA-0AE2A73E7BA0Q33389945-9E4D0ECC-F00B-4F63-9E51-1930E5F17009Q33390198-F35F0422-CB19-4063-B9A8-C7569DD62BC2Q33393864-90519604-D3DE-4EA3-9DEA-1B66017203E7Q33395944-12D32417-0BB6-430F-BEAD-0AAB69199707Q33398546-767F0410-C05B-4DF2-8C30-A8699A6B0C6FQ33399052-F85C5394-DF60-4214-A4A1-CAF34D15B482Q33400211-65C65F9C-BE09-46BF-9E73-2B2C5098EF08Q33401386-DFFC9CA7-A08C-45E4-921E-A73484DA3067Q33401619-3AC39044-538F-4F43-9580-B7A969B39E99Q33402372-1B29EC71-9A00-4DC0-B1CC-1E44DD184C76Q33402827-5A75114B-F90E-46A9-99CA-5E8F41DED7A2Q33404847-46F32CAE-9BAD-480C-8276-9923E56FE543Q33405522-299FDA80-F3CA-4C7F-87B0-E4FD461C30CEQ33408788-45A005C7-D2C4-438A-9166-315238E3ACC8Q33409198-1179875D-71FF-4D3F-A701-DB22619881E2Q33409307-E1FAD01C-3BB9-421B-BBCB-C899155B19A0Q33410276-3F03AFC1-766E-4AF9-B5CD-9BF4573B428AQ33411577-18214917-3A66-45D4-AF7D-5A16E43F4E6FQ33412073-401B0474-FB77-4A99-8CE5-D052F4842675Q33412325-16AF3A65-3C30-4A31-9193-3A8F415C1544Q33412640-8226645F-0FD9-4A6C-A18C-31DBE1768E9FQ33415753-140D72C8-B30F-49ED-AC3E-298F26F1CF3A
P2860
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Factor H autoantibodies in aty ...... e with CFHR1/CFHR3 deficiency.
@ast
Factor H autoantibodies in aty ...... e with CFHR1/CFHR3 deficiency.
@en
type
label
Factor H autoantibodies in aty ...... e with CFHR1/CFHR3 deficiency.
@ast
Factor H autoantibodies in aty ...... e with CFHR1/CFHR3 deficiency.
@en
prefLabel
Factor H autoantibodies in aty ...... e with CFHR1/CFHR3 deficiency.
@ast
Factor H autoantibodies in aty ...... e with CFHR1/CFHR3 deficiency.
@en
P2093
P50
P1433
P1476
Factor H autoantibodies in aty ...... e with CFHR1/CFHR3 deficiency.
@en
P2093
Christine Skerka
Christoph Licht
Heiko Richter
Stefanie Strobel
Svante L H Zipfel
P304
P356
10.1182/BLOOD-2007-09-109876
P407
P577
2007-11-15T00:00:00Z